Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEquity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Gsk (GLAXF) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for Gsk (GLAXF) over the last 17 years, with Q3 2025 value amounting to $35.1 million.

  • Gsk's Interest & Investment Income fell 1563.91% to $35.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $241.7 million, marking a year-over-year increase of 2758.59%. This contributed to the annual value of $155.9 million for FY2024, which is 902.54% up from last year.
  • According to the latest figures from Q3 2025, Gsk's Interest & Investment Income is $35.1 million, which was down 1563.91% from $66.7 million recorded in Q2 2025.
  • In the past 5 years, Gsk's Interest & Investment Income ranged from a high of $77.0 million in Q4 2023 and a low of $1.3 million during Q4 2021
  • Moreover, its 5-year median value for Interest & Investment Income was $32.8 million (2022), whereas its average is $34.4 million.
  • In the last 5 years, Gsk's Interest & Investment Income plummeted by 8425.78% in 2021 and then soared by 233633.03% in 2022.
  • Gsk's Interest & Investment Income (Quarter) stood at $1.3 million in 2021, then soared by 2336.33% to $32.8 million in 2022, then skyrocketed by 134.31% to $77.0 million in 2023, then fell by 6.6% to $71.9 million in 2024, then crashed by 51.2% to $35.1 million in 2025.
  • Its Interest & Investment Income was $35.1 million in Q3 2025, compared to $66.7 million in Q2 2025 and $68.0 million in Q1 2025.